Soheil Hassanipoura News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Soheil hassanipoura. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Soheil Hassanipoura Today - Breaking & Trending Today

Fujifilm's Avigan shows no significant benefit on COVID-19 mortality - study


Article content
TOKYO A study of global trials of Fujifilm Holdings Corp’s antiviral drug Avigan suggests it has little benefit for COVID-19 patients once their symptoms become serious.
The meta-analysis of nine clinical trials showed the drug, known generically as favipiravir, helped patients early on in their hospitalization, according to the preprint of a study posted Wednesday on the medical website medRxiv.
We apologize, but this video has failed to load.
Try refreshing your browser, or
Fujifilm s Avigan shows no significant benefit on COVID-19 mortality - study Back to video
But it failed to demonstrate statistically significant results in reducing mortality among those with mild to moderate COVID-19. ....

Soheil Hassanipoura , Shinzo Abe , Iran Guilan University Of Medical Sciences , Fujifilm Holdings Corp , Guilan University , Japanese Prime Minister Shinzo Abe , Rocky Swift , Lincoln Feast , புஜிஃபில்ம் ஹோல்டிங்ஸ் கார்ப் , பாறை ஸ்விஃப்ட் , லிங்கன் விருந்து ,

Fujifilm's Avigan shows no significant benefit on COVID-19 mortality: study


Fujifilm s Avigan shows no significant benefit on COVID-19 mortality: study
Reuters
18/02/2021
TOKYO (Reuters) - A study of global trials of Fujifilm Holdings Corp s antiviral drug Avigan suggests it has little benefit for COVID-19 patients once their symptoms become serious.
The meta-analysis of nine clinical trials showed the drug, known generically as favipiravir, helped patients early on in their hospitalisation, according to the preprint of a study posted Wednesday on the medical website medRxiv.
But it failed to demonstrate statistically significant results in reducing mortality among those with mild to moderate COVID-19.
We should consider that perhaps the use of antivirals once the patient has symptoms is too late and this would explain their low efficacy in the clinical setting, wrote the authors, led by Soheil Hassanipoura of Iran s Guilan University of Medical Sciences. ....

Soheil Hassanipoura , Shinzo Abe , Iran Guilan University Of Medical Sciences , Fujifilm Holdings Corp , Guilan University , Japanese Prime Minister Shinzo Abe , Rocky Swift , Lincoln Feast , புஜிஃபில்ம் ஹோல்டிங்ஸ் கார்ப் , பாறை ஸ்விஃப்ட் , லிங்கன் விருந்து ,